VAISHALI PHARMA
Quarterly Results Analysis [Dec2024]
VAISHALI PHARMA Quarterly Results
Standalone | Dec2024 UnAudited |
Sep2024 Audited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 Audited |
Sep2023 Audited |
Jun2023 UnAudited |
Mar2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹28 Cr | ₹21 Cr | ₹18 Cr | ₹32 Cr | ₹28 Cr | ₹13 Cr | ₹13 Cr | ₹26 Cr |
Expenses | ₹27 Cr | ₹18 Cr | ₹16 Cr | ₹39 Cr | ₹25 Cr | ₹10 Cr | ₹11 Cr | ₹25 Cr |
Operating Income | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹-7 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr |
Other Income | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr |
Depreciation | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Profit Before Tax | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹-6 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr |
Profit After Tax | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹-5 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹0 Cr |
EPS | ₹1.11 | ₹0.15 | ₹0.14 | ₹-0.44 | ₹1.99 | ₹0.16 | ₹0.15 | ₹0.04 |
Industry Peers & Returns | 1W | 1M | 1Y |
VAISHALI PHARMA | -8% | 4.8% | 0.5% |
SUN PHARMACEUTICAL INDUSTRIES | -2% | -0.8% | 16.6% |
CIPLA | 0.7% | 1.4% | 3.7% |
DR REDDYS LABORATORIES | 0.1% | -8.5% | 0.7% |
ZYDUS LIFESCIENCES | -0.9% | -1% | 24% |
DIVIS LABORATORIES | -2.7% | 3.5% | 66.7% |
MANKIND PHARMA | -1.7% | -3.2% | 12% |
TORRENT PHARMACEUTICALS | 2.8% | -1.5% | 23.1% |
LUPIN | 2.8% | 0.7% | 37% |
VAISHALI PHARMA Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 34.29 % |
Y-o-Y | 0.07 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹28 Cr | 34.29 | |
Sep2024 | ₹21 Cr | 14.97 | |
Jun2024 | ₹18 Cr | -44.19 | |
Mar2024 | ₹32 Cr | 16.14 | |
Dec2023 | ₹28 Cr | 121.99 | |
Sep2023 | ₹13 Cr | -6.38 | |
Jun2023 | ₹13 Cr | -48.84 | |
Mar2023 | ₹26 Cr | - |
VAISHALI PHARMA Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -43.55 % |
Y-o-Y | -53.73 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹1 Cr | -43.55 | |
Sep2024 | ₹2 Cr | 3.24 | |
Jun2024 | ₹2 Cr | Positive | |
Mar2024 | ₹-7 Cr | Negative | |
Dec2023 | ₹3 Cr | 11.06 | |
Sep2023 | ₹3 Cr | 15.11 | |
Jun2023 | ₹2 Cr | 195.65 | |
Mar2023 | ₹1 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -57.99 % |
Y-o-Y | -53.78 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 4.89% | -57.99 | |
Sep2024 | 11.64% | -10.19 | |
Jun2024 | 12.96% | Positive | |
Mar2024 | -20.93% | Negative | |
Dec2023 | 10.58% | -49.98 | |
Sep2023 | 21.15% | 22.97 | |
Jun2023 | 17.2% | 477.18 | |
Mar2023 | 2.98% | - |
VAISHALI PHARMA Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -26.69 % |
Y-o-Y | -31.69 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹1 Cr | -26.69 | |
Sep2024 | ₹2 Cr | 15.77 | |
Jun2024 | ₹2 Cr | Positive | |
Mar2024 | ₹-5 Cr | Negative | |
Dec2023 | ₹2 Cr | 23.88 | |
Sep2023 | ₹2 Cr | 7.44 | |
Jun2023 | ₹2 Cr | 264.60 | |
Mar2023 | ₹0 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -45.35 % |
Y-o-Y | -31.70 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 5.17 % | -45.35 | |
Sep2024 | 9.46 % | 0.64 | |
Jun2024 | 9.4 % | Positive | |
Mar2024 | -14.46 % | Negative | |
Dec2023 | 7.57 % | -44.17 | |
Sep2023 | 13.56 % | 14.72 | |
Jun2023 | 11.82 % | 612.05 | |
Mar2023 | 1.66 % | - |
VAISHALI PHARMA Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 640.00 % |
Y-o-Y | -44.22 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹1.11 | 640.00 | |
Sep2024 | ₹0.15 | 7.14 | |
Jun2024 | ₹0.14 | Positive | |
Mar2024 | ₹-0.44 | Negative | |
Dec2023 | ₹1.99 | 1,143.75 | |
Sep2023 | ₹0.16 | 6.67 | |
Jun2023 | ₹0.15 | 275.00 | |
Mar2023 | ₹0.04 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD